Skip to content
AnalystLens

WASTE MANAGEMENT INC 8-K Report, Material Agreement (Jun 5, 2024)

Reports
Material Agreements·Regulation FD·Exhibits & Filings
Filing Date
Filed June 5, 2024
Period End
June 3, 2024
Security
WM
In the record · 2016–202610-K1210-Q328-K132

WM filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 132 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Sep ’18Sep ’18
  2. Deal closed8-K · Oct ’20Oct ’20
  3. Material agreement8-K · Jun ’22Jun ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed June 5, 2024. Cited figures are marked; the original filing is the authoritative source.

Waste Management, Inc. (WM) has announced a significant material definitive agreement to acquire Stericycle, Inc. for $62.00a per share in an all-cash transaction.

This acquisition is structured as a merger whereby Stericycle will become an indirect wholly-owned subsidiary of Waste Management. The deal is subject to customary closing conditions, including Stericycle shareholder approval and regulatory approvals, such as those under the Hart-Scott-Rodino Antitrust Improvements Act.

The agreement outlines specific provisions for handling Stericycle stock options and restricted stock units (RSUs) upon closing, with some RSUs being converted into WM stock awards for continuing employees. Termination clauses and fees are also detailed, with Stericycle potentially owing a fee to WM under certain conditions, and WM potentially owing a larger fee to Stericycle if regulatory hurdles prevent the merger.

Key Highlights

  1. Waste Management (WM) to acquire Stericycle, Inc. for $62.00 per share in cash.
  2. The transaction is structured as a merger, making Stericycle an indirect wholly-owned subsidiary of WM.
  3. The deal is subject to Stericycle shareholder approval and customary regulatory approvals, including antitrust reviews.
  4. Stericycle stock options will be cashed out if the exercise price is below the merger consideration.
  5. Stericycle RSUs held by continuing employees will be converted into WM RSUs; others will be cashed out.
  6. WM has agreed to use reasonable best efforts to obtain regulatory approvals, with limitations on required divestitures or remedies.
  7. Specific termination fees are outlined for both parties under various scenarios, including regulatory challenges.

Frequently Asked Questions

  1. What is the total value of the acquisition?

    The filing states that each share of Stericycle common stock will be converted into the right to receive $62.00 per share in cash. To determine the total value, one would need to multiply this per-share price by the total number of outstanding Stericycle shares, which is not provided in this 8-K filing but would be publicly available in Stericycle's filings.

  2. What conditions must be met for the merger to close?

    The closing is subject to several conditions, including the affirmative vote of Stericycle stockholders, customary regulatory approvals (like HSR), and the absence of any legal orders preventing the merger. Both WM and Stericycle must also ensure the accuracy of their representations and warranties and performance of their covenants, with WM also needing to avoid a material adverse effect on Stericycle.

  3. What happens to Stericycle employee stock options and RSUs?

    Vested Stericycle stock options with an exercise price below $62.00 will be cancelled and converted into a cash payment equal to the difference between the merger consideration and the exercise price. Stericycle RSUs held by employees continuing with WM will be converted into WM RSUs on substantially the same terms. RSUs held by employees terminating employment will be cashed out at the merger consideration, with performance-based awards converted at target levels.

  4. Are there any termination fees associated with this agreement?

    Yes, there are termination fees. Stericycle may owe WM $175 million if Stericycle terminates the agreement to accept a superior proposal or if the Stericycle board changes its recommendation. WM may owe Stericycle $262.5 million if the merger is terminated due to failure to obtain required regulatory approvals or if an injunction arises under specific laws, provided other closing conditions are met.